Sharp, a part of UDG Healthcare, a global leader in contract packaging and clinical supply services, announced an investment of $11 million to increase its global cold storage and syringe assembly capacity in response to market demand.
The additional investment in Groninger labelling machines has doubled Sharp’s syringe assembly capacity at its Allentown, US facility, which will provide additional manufacturing speed capacity and in-line safety device assembly when installed. Cold storage capacity will also be increased by 61% at the site with a $1.5 million investment into caged cold storage as part of the company’s drive to meet demand in the injectable device and biologics markets.
At the company’s site in Belgium, investment in additional equipment, including Groninger labelling machines as well as the installation of a high-speed syringe assembly Bausch+Ströbel machine, has trebled syringe assembly capacity. New cold storage facilities at Sharp’s Oudehaske site in the Netherlands has increased vial labelling capabilities and increased the company’s cold storage capacity in northern Europe by 14%. The latest investment in the Biotechnology Center of Excellence on Sharp’s Allentown campus has further increased its ability to handle specialty packaging requirements.
Sharp, part of UDG healthcare, has built its reputation for delivering cost-effective blister packaging, bottling, secondary assembly and labelling of injectable presentations, compliance packaging, formulation and manufacturing services, label design and printing. Sharp is also a world leader in ’Track and Trace’ and serialization services, with over nine years’ experience in implementing serialized solutions.